Paushak Limited has announced its audited financial results for the quarter and year ended March 31, 2026, following a Board meeting held on May 5, 2026. The company reported revenue from operations of ₹5,514 Lakhs for the quarter ended March 31, 2026, representing a 13.0% increase compared to ₹4,880 Lakhs in the previous quarter ended December 31, 2025. Compared to the corresponding quarter of the previous year (₹5,236 Lakhs), the revenue saw a growth of 5.3%. Net profit after tax for the current quarter stood at ₹1,251 Lakhs, a significant 102.8% increase from ₹617 Lakhs in the preceding quarter and a 30.3% rise from ₹960 Lakhs in the same period last year. Additionally, the Board has recommended a dividend of ₹2.50 per equity share (50%) for the financial year 2025-26, subject to shareholder approval.

Paushak Limited, an Alembic Group company, is India’s largest specialized phosgene-based specialty chemical manufacturer. Based in Gujarat, the company serves diverse sectors including pharmaceuticals, agrochemicals, and performance chemicals, maintaining a strong commitment to quality and sustainability through its ISO-certified integrated manufacturing facilities.